ArticleKidney international reports2022

Concomitant Anti-GBM Glomerulonephritis and Acute Interstitial Nephritis Following Programmed Death Receptor-1 Blockade With Nivolumab.

Takashi Tani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.